Discover the latest business news including rising gas prices, Zepbound shipments, At Home bankruptcy, and the Federal Reserve meeting.

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Lilly’s announcement Tuesday focused on single-dose vials for people paying out of pocket for the two lowest doses of Zepbound, priced at $399 and $549, and did not mention the savings-card ...

Copyright: © 2018 Elsevier Ltd. All rights reserved.

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of ...

Dr. Xu Chen presented the results of a dose-escalation phase I trial evaluating intravesical disitamab vedotin (RC48) for patients with HER-2 expressing high-risk, non-muscle invasive bladder cancer ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

The analysis did not include other GLP-1 drugs, including Novo’s Ozempic and Eli Lilly’s LLY.N Zepbound, which are not approved to treat obesity in adolescents, or compounded versions of these ...

We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in children with status asthmaticus. Design Retrospective analysis of inpatient medical records and ...

Moderna's new option is a lower-dose version that is a step toward next-generation coronavirus vaccines. It’s called mNexspike. Moderna’s new COVID-19 vaccine is recommended as another option ...

ISB 2001 demonstrated high response rates at active dose levels, with 33 patients treated at ≥ 50 µg/kg (dose levels 3–9). Responses were durable and deepened over time ...